- Home
- CLMB vs RGNX Comparison
CLMB vs RGNX Comparison
Compare CLMB & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMB
- RGNX
- Stock Information
- Founded
- CLMB 1982
- RGNX 2008
- Country
- CLMB United States
- RGNX United States
- Employees
- CLMB N/A
- RGNX N/A
- Industry
- CLMB Retail: Computer Software & Peripheral Equipment
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLMB Technology
- RGNX Health Care
- Exchange
- CLMB Nasdaq
- RGNX Nasdaq
- Market Cap
- CLMB 417.8M
- RGNX 459.1M
- IPO Year
- CLMB N/A
- RGNX 2015
- Fundamental
- Price
- CLMB $120.80
- RGNX $9.63
- Analyst Decision
- CLMB Buy
- RGNX Strong Buy
- Analyst Count
- CLMB 1
- RGNX 12
- Target Price
- CLMB $136.00
- RGNX $36.36
- AVG Volume (30 Days)
- CLMB 36.2K
- RGNX 673.8K
- Earning Date
- CLMB 10-30-2024
- RGNX 11-06-2024
- Dividend Yield
- CLMB 0.56%
- RGNX N/A
- EPS Growth
- CLMB 39.90
- RGNX N/A
- EPS
- CLMB 3.68
- RGNX N/A
- Revenue
- CLMB $410,631,000.00
- RGNX $84,327,000.00
- Revenue This Year
- CLMB $25.65
- RGNX $7.91
- Revenue Next Year
- CLMB $7.98
- RGNX $214.75
- P/E Ratio
- CLMB $32.78
- RGNX N/A
- Revenue Growth
- CLMB 22.89
- RGNX N/A
- 52 Week Low
- CLMB $45.79
- RGNX $8.54
- 52 Week High
- CLMB $124.50
- RGNX $28.80
- Technical
- Relative Strength Index (RSI)
- CLMB 67.85
- RGNX 45.77
- Support Level
- CLMB $116.80
- RGNX $10.24
- Resistance Level
- CLMB $124.50
- RGNX $12.11
- Average True Range (ATR)
- CLMB 5.42
- RGNX 0.81
- MACD
- CLMB 0.87
- RGNX 0.15
- Stochastic Oscillator
- CLMB 85.51
- RGNX 29.72
About CLMB Climb Global Solutions Inc.
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The Company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.